| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
L | KFI | FI | PI | | Forsteo | Stück | 266.45 | 305.75 | 10% | | Injektionslösung in Fertigspritze: Teriparatidum Adnr 250 µg/ml | Eli Lilly (Suisse) SA | B / SL / SO | FB | | G |  |
L | | FI | PI | | Teriparatid-Mepha | | 188.36 | 225.60 | 10% | | Injektionslösung im Fertigpen: Teriparatidum 250 µg/ml | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Movymia | | 239.81 | 278.40 | 10% | | Injektionslösung: Teriparatidum Adnr 250 µg/ml | Spirig HealthCare AG | B / SL | FB | | G |  |
L | | FI | PI | | Terrosa | | 239.81 | 278.40 | 10% | | Injektionslösung: Teriparatidum Adnr 250 µg/ml | Gedeon Richter (Schweiz) AG | ● B / SL | FB | | G |  |
L | | FI | PI | | Terrosa | | 239.81 | 278.40 | 10% | | Injektionslösung: Teriparatidum Adnr 250 µg/ml | Gedeon Richter (Schweiz) AG | ● B / SL | FB | | G |  |
L | | FI | PI | | Livogiva 20 mcg/80 mcl | | 239.81 | 278.40 | 10% | | Injektionslösung im Fertigpen: Teriparatidum Adnr 250 µg/ml | Future Health Pharma GmbH | B / SL | FB | | G |  |
L | | FI | PI | | Sondelbay 20 mcg/80 mcl | | 239.81 | 278.40 | 10% | | Injektionslösung in einem Fertiginjektor: Teriparatidum Adnr 250 µg/ml | Accord Healthcare AG | B / SL | FB | | G |  |
| | FI | PI | | Movymia | 3 | PA | PA | k.A. | | Injektionslösung: Teriparatidum Adnr 250 µg/ml | Spirig HealthCare AG | B | FB | | G |  |
| | FI | PI | | Terrosa | 3 | PA | PA | k.A. | | Injektionslösung: Teriparatidum Adnr 250 µg/ml | Gedeon Richter (Schweiz) AG | B | FB | | G |  |
|
L | | FI | PI | | Tymlos 80 μg/40 μL | | 284.38 | 325.70 | 10% | | Injektionslösung in Fertigspritze: Abaloparatidum 2000 µg/ml | Labatec Pharma SA | B / SL | FB | | G |  |
|
L | | FI | PI | | Miacalcic 100 | 5 Ampulle(n) | 41.73 | 61.80 | 10% | | Injektionslösung: Calcitoninum Salmonis 100 UI/ml | Future Health Pharma GmbH | B / SL | FB | | G |  |
L | | FI | PI | | Miacalcic 200 | | 39.67 | 59.55 | 10% | | Nasenspray: Calcitoninum Salmonis 200 UI | Future Health Pharma GmbH | B / SL | FB | | G |  |
| | FI | | | Miacalcic 50 | 5 | PA | PA | k.A. | | Injektionslösung: Calcitoninum Salmonis 50 UI/ml | Future Health Pharma GmbH | B | FB | | G |  |
| | FI | PI | | Miacalcic mite 100 | | PA | PA | k.A. | | Nasenspray: Calcitoninum Salmonis 100 UI | Future Health Pharma GmbH | B | FB | | G |  |
|
L | | FI | PI | | Cinacalcet Spirig HC 30 mg | 28 | 110.14 | 137.35 | 10% | | Filmtabletten: Cinacalcetum 30 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | FI | | | Cinacalcet Spirig HC 60 mg | 28 | 193.20 | 228.50 | 10% | | Filmtabletten: Cinacalcetum 60 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | FI | | | Cinacalcet Spirig HC 90 mg | 28 | 273.00 | 316.10 | 10% | | Filmtabletten: Cinacalcetum 90 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Cinacalcet Devatis 30 mg | 28 | 106.50 | 133.60 | 10% | | Filmtabletten: Cinacalcetum 30 mg | Devatis AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Cinacalcet Devatis 60 mg | 28 | 190.00 | 225.25 | 10% | | Filmtabletten: Cinacalcetum 60 mg | Devatis AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Cinacalcet Devatis 90 mg | 28 | 270.00 | 313.05 | 10% | | Filmtabletten: Cinacalcetum 90 mg | Devatis AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Cinacalcet-Mepha 30 mg | 28 | 128.50 | 156.15 | 10% | | Filmtabletten: Cinacalcetum 30 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Cinacalcet-Mepha 60 mg | 28 | 225.40 | 261.55 | 10% | | Filmtabletten: Cinacalcetum 60 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Cinacalcet-Mepha 90 mg | 28 | 318.50 | 362.80 | 10% | | Filmtabletten: Cinacalcetum 90 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| KFI | FI | PI | | Mimpara 30 mg | 28 Tablette(n) | 149.32 | 177.55 | k.A. | | Filmtabletten: Cinacalcetum 30 mg | Amgen Switzerland AG | B | FB | | G |  |
| KFI | FI | PI | | Mimpara 60 mg | 28 Tablette(n) | 261.92 | 299.00 | k.A. | | Filmtabletten: Cinacalcetum 60 mg | Amgen Switzerland AG | B | FB | | G |  |
| KFI | FI | PI | | Mimpara 90 mg | 28 Tablette(n) | 370.11 | 415.75 | k.A. | | Filmtabletten: Cinacalcetum 90 mg | Amgen Switzerland AG | B | FB | | G |  |
|
L | | FI | | | Zemplar 2 ug/1ml | 5 Durchstechflasche(n) | 47.23 | 67.80 | 10% | | Injektionslösung: Paricalcitolum 2 µg/ml | AbbVie AG | B / SL | FB | | G |  |
L | | FI | | | Zemplar 5 ug/1ml | 5 Durchstechflasche(n) | 97.97 | 122.95 | 10% | | Injektionslösung: Paricalcitolum 5 µg/ml | AbbVie AG | B / SL | FB | | G |  |
L | | FI | PI | | Zemplar 1 µg | 28 Kapsel(n) | 109.46 | 135.45 | 10% | | Weichkapseln: Paricalcitolum 1 µg | AbbVie AG | B / SL | FB | | G |  |
L | | FI | PI | | Zemplar 2 µg | 28 Kapsel(n) | 218.90 | 254.50 | 10% | | Weichkapseln: Paricalcitolum 2 µg | AbbVie AG | B / SL | FB | | G |  |
| | FI | | | Zemplar 10 ug/2ml | 5 Durchstechflasche(n) | PA | PA | k.A. | | Injektionslösung: Paricalcitolum 10µg / 2ml | AbbVie AG | B | FB | | G |  |
|
L | | FI | | PS | Parsabiv 2.5 mg | 6 | 93.72 | 118.35 | 10% | | Injektionslösung: Etelcalcetidum 2.5 mg | Amgen Switzerland AG | B / SL | FB | | G |  |
L | | FI | | PS | Parsabiv 5.0 mg | 6 | 161.20 | 191.75 | 10% | | Injektionslösung: Etelcalcetidum 5 mg | Amgen Switzerland AG | B / SL | FB | | G |  |
L | | FI | | PS | Parsabiv 10.0 mg | 6 | 281.17 | 322.20 | 10% | | Injektionslösung: Etelcalcetidum 10 mg | Amgen Switzerland AG | B / SL | FB | | G |  |
|
L | | FI | PI | | Rayaldee 30 µg | 30 | 88.18 | 112.30 | 10% | | Weichkapseln retardiert: Calcifediolum 30 µg | Vifor Fresenius Medical Care Renal Pharma Ltd. | B / SL | FB | | G |  |